Alnylam (ALNY) Stock Soars 30% on Heart Disease Drug Success

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

The challenge for Alnylam now will be to find and diagnose patients with the condition known as ATTR-CM, which is considered rare.

The post Alnylam (ALNY) Stock Soars 30% on Heart Disease Drug Success appeared first on InvestorPlace.

More From InvestorPlace

• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• Legendary Investor Predicts: “Forget A.I. THIS Technology Is the Future”